EC approves Eliquis

The European Commission approved Eliquis apixaban from Bristol-Myers Squibb Co. (NYSE:BMY) and partner Pfizer Inc. (NYSE:PFE) to prevent venous thromboembolic events (VTE) in adults who have undergone...